Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RENTON HOLLINGS −$249K Director sold 31% of stake

Reading 67 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-03 LOUMEAU ERIC J Chief Legal Officer Grant or award · Stock Option (right to buy) +79,780 79,780
2024-01-03 LOUMEAU ERIC J Chief Legal Officer Grant or award · Restricted Stock Unit +29,150 29,150
2024-01-03 MULROY DENNIS Chief Financial Officer Grant or award · Stock Option (right to buy) +90,780 90,780
2024-01-03 MULROY DENNIS Chief Financial Officer Grant or award · Restricted Stock Unit +33,170 33,170
2024-01-03 FENTON DENNIS M Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 FENTON DENNIS M Director Grant or award · Restricted Stock Unit +6,030 6,030
2024-01-03 Faga Daniel CEO Grant or award · Stock Option (right to buy) +379,620 379,620
2024-01-03 Faga Daniel CEO Grant or award · Restricted Stock Unit +138,710 138,710
2024-01-03 Ware J. Anthony Director Grant or award · Stock Option (right to buy) +16,510 16,510
2024-01-03 Ware J. Anthony Director Grant or award · Restricted Stock Unit +6,030 6,030
2023-11-22 LOUMEAU ERIC J Chief Legal Officer Sale −882 $14.19 $13K 0
2023-09-18 LOUMEAU ERIC J Chief Legal Officer Sale −3,895 $19.32 $75K 882
2023-09-18 MULROY DENNIS Chief Financial Officer Sale −3,895 $19.32 $75K 964
2023-09-15 Orwin John A Director Grant or award · Stock Option (right to buy) +3,311 3,311
2023-09-15 Orwin John A Director Grant or award · Stock Option (right to buy) +10,600 10,600
2023-09-15 Orwin John A Director Grant or award · Restricted Stock Unit +2,035 2,035
2023-09-15 Orwin John A Director Grant or award · Restricted Stock Unit +3,900 3,900
2023-09-14 Lizzul Paul F. Chief Medical Officer Exercise or conversion +6,000 8,632
2023-09-14 Lizzul Paul F. Chief Medical Officer Sale −2,105 $19.48 $41K 6,527
2023-09-14 Lizzul Paul F. Chief Medical Officer Exercise or conversion · Restricted Stock Unit −6,000 6,000

Page 19 of 27 · 522 trades